US lawmakers object to PTO's control of fees in patent reform bill
This article was originally published in SRA
Representatives Harold Rogers (Republican - Kentucky), chairman of the House Appropriations Committee, and Paul Ryan (Republican - Wisconsin), chairman of the House Budget Committee, have raised objections to a measure in the patent reform bill introduced in the House in March that would permit the US Patent & Trademark Office to set its own fees1,2.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.